Mats Van Delen

2PUBLICATIONS
2CO-AUTHORS
Nanotoxicology, health and safetyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 03, 2024
A systematic review and meta-analysis of clinical trials assessing safety and efficacy of human extracellular vesicle-based therapy.

Mats Van Delen, Judith Derdelinckx, Kristien Wouters

|Dec 11, 2022
Tolerogenic Dendritic Cells Induce Apoptosis-Independent T Cell Hyporesponsiveness of SARS-CoV-2-Specific T Cells in an Antigen-Specific Manner.

Mats Van Delen, Ibo Janssens, Amber Dams

Pageof 1